Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

67.61
+1.071.61%
Post-market: 66.26-1.3500-2.00%19:09 EST
Volume:2.93M
Turnover:193.44M
Market Cap:13.11B
PE:-17.89
High:67.66
Open:66.63
Low:64.33
Close:66.54
52wk High:84.94
52wk Low:28.33
Shares:193.86M
Float Shares:151.20M
Volume Ratio:0.72
T/O Rate:1.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7800
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-33.83%
PB:-6.28
PE(LYR):-17.86

Loading ...

Stock Track | BridgeBio Pharma Plummets 5.01% Intraday Amid Mixed Analyst Target Price Revisions

Stock Track
·
Yesterday

BridgeBio Pharma (BBIO) Gets a Buy from Jefferies

TIPRANKS
·
Feb 25

BridgeBio Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Feb 25

BridgeBio price target raised to $95 from $86 at Truist

TIPRANKS
·
Feb 25

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Feb 25

BridgeBio Pharma, Inc. : Oppenheimer Cuts Target Price to $81 From $83

THOMSON REUTERS
·
Feb 25

BridgeBio price target raised to $125 from $100 at Evercore ISI

TIPRANKS
·
Feb 25

Stock Track | BridgeBio Pharma Soars 5.40% in Pre-Market on Multiple Analyst Price Target Hikes

Stock Track
·
Feb 25

Morgan Stanley Lifts Price Target on BridgeBio Pharma to $98 From $96, Keeps Overweight Rating

MT Newswires Live
·
Feb 25

Barclays Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Feb 25

U.S. RESEARCH ROUNDUP-Chevron, GoDaddy, HP

Reuters
·
Feb 25

BridgeBio Pharma Inc : Leerink Partners Raises Target Price to $98 From $95

THOMSON REUTERS
·
Feb 25

BridgeBio Pharma Publishes Corporate Presentation on Rare Genetic Disease Drug Pipeline and Attruby Commercial Momentum

Reuters
·
Feb 25

Earnings Flash (BBIO) BridgeBio Pharma Posts Q4 Loss $1, vs. FactSet Est of $0.71 Loss

MT Newswires Live
·
Feb 25

BridgeBio reports Q4 EPS ($1.00), consensus (67c)

TIPRANKS
·
Feb 25

BridgeBio Q4 revenue jumps on Attruby sales

Reuters
·
Feb 25

BridgeBio Pharma Q4 EPS $(1.00) Misses $(0.66) Estimate, Sales $154.178M Beat $146.844M Estimate

Benzinga
·
Feb 25

BridgeBio posts USD 154.2 million Q4 total revenues, net on 35% QoQ net product revenue growth

Reuters
·
Feb 25

BRIEF-BridgeBio Pharma Q4 Net Income USD -194.635 Million

Reuters
·
Feb 25

BridgeBio Pharma: on Track for 1H 2026 Nda Submission Post Positive Phase 3 Calibrate Results for Encaleret in Adh1

THOMSON REUTERS
·
Feb 25